- Home
- BCYC vs DSU Comparison
BCYC vs DSU Comparison
Compare BCYC & DSU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCYC
- DSU
- Stock Information
- Founded
- BCYC 2009
- DSU 1998
- Country
- BCYC United Kingdom
- DSU United States
- Employees
- BCYC N/A
- DSU N/A
- Industry
- BCYC Biotechnology: Pharmaceutical Preparations
- DSU Finance Companies
- Sector
- BCYC Health Care
- DSU Finance
- Exchange
- BCYC Nasdaq
- DSU Nasdaq
- Market Cap
- BCYC 529.8M
- DSU 548.1M
- IPO Year
- BCYC 2019
- DSU N/A
- Fundamental
- Price
- BCYC $7.10
- DSU $10.56
- Analyst Decision
- BCYC Buy
- DSU
- Analyst Count
- BCYC 12
- DSU 0
- Target Price
- BCYC $22.91
- DSU N/A
- AVG Volume (30 Days)
- BCYC 261.8K
- DSU 148.2K
- Earning Date
- BCYC 08-08-2025
- DSU 01-01-0001
- Dividend Yield
- BCYC N/A
- DSU 10.06%
- EPS Growth
- BCYC N/A
- DSU N/A
- EPS
- BCYC N/A
- DSU N/A
- Revenue
- BCYC $19,281,000.00
- DSU N/A
- Revenue This Year
- BCYC $7.35
- DSU N/A
- Revenue Next Year
- BCYC N/A
- DSU N/A
- P/E Ratio
- BCYC N/A
- DSU N/A
- Revenue Growth
- BCYC N/A
- DSU N/A
- 52 Week Low
- BCYC $6.10
- DSU $9.22
- 52 Week High
- BCYC $28.67
- DSU $11.40
- Technical
- Relative Strength Index (RSI)
- BCYC 37.11
- DSU 53.07
- Support Level
- BCYC $7.25
- DSU $10.43
- Resistance Level
- BCYC $7.68
- DSU $10.59
- Average True Range (ATR)
- BCYC 0.42
- DSU 0.06
- MACD
- BCYC -0.07
- DSU -0.00
- Stochastic Oscillator
- BCYC 12.80
- DSU 68.42
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
About DSU Blackrock Debt Strategies Fund Inc.
Blackrock Debt Strategies Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide current income by investing in a diversified portfolio of U.S. companies' debt instruments including corporate loans. The fund's secondary investment objective is to provide capital appreciation.